Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qiren Tongmai Mixture is a traditional Chinese medicine (TCM) botanical formulation used primarily for the treatment of cardiovascular and cerebrovascular diseases. It is designed to address conditions characterized by "qi deficiency and blood stasis," according to TCM theory. The mixture has been studied in clinical settings for its effects on patients recovering from cerebral infarction (ischemic stroke) with qi deficiency and blood stasis syndrome, aiming to improve neurological function and recovery outcomes[1]. While the precise composition of the mixture is not detailed in available sources, similar TCM formulas often contain a combination of herbal ingredients intended to promote blood circulation, enhance energy (qi), reduce stasis, and support vascular health. The mechanism of action likely involves modulation of vascular function, anti-inflammatory effects, improvement in microcirculation, and possibly neuroprotective actions through multiple biological pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qiren Tongmai Mixture.